LEX-WK-4CCS9J9Ecrawled 2021-11-02 10:22Z
FDA’s Section 804 Prescription Drug Importation Program and 801(d)(1)(B) Guidance
Kevin Madagan · Cori Annapolen Goldberg · Sung Park · Catherine David · Life Sciences Legal Update · Published January 14, 2020
Work details
- author
- Kevin Madagan · Cori Annapolen Goldberg · Sung Park · Catherine David
- firm or organization
- Reed Smith LLP
- publication
- Life Sciences Legal Update
- practice area
- Food, Drug & Agriculture
- published
- 2020-01-14
Citation
Kevin Madagan, Cori Annapolen Goldberg, Sung Park, Catherine David, FDA’s Section 804 Prescription Drug Importation Program and 801(d)(1)(B) Guidance, Life Sciences Legal Update (January 14, 2020) [The Library at LexBlog, LEX-WK-4CCS9J9E, lexpid.org/4CCS9J9E]